Fundraising Fox
Arrivo BioVentures
Morrisville, US · Founded 2015 · 15 employees on LinkedIn · 3 known investors
Find your way into Arrivo BioVentures
Sign up to see every warm intro you have to Arrivo BioVentures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arrivo BioVentures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist. The company partners with Mayo Clinic and Daiichi Sankyo to advance first-of-its-kind therapies.
Founders & leadership
Investors · 3
How we know: Rex Health Ventures's portfolio page · the company's own site · funding news · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: Solas BioVentures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 1 round · 2023
▶$43.2MraisedNov 2023 · 58 investors · BiotechnologyRule 506(b)
- Karen AdamsExecutive Officer
- Stephen E. ButtsExecutive Officer
- Offering amount
- $45.3M
- Amount sold
- $43.2M
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Arrivo BioVentures do?
- Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist. The company partners with Mayo Clinic and Daiichi Sankyo to advance first-of-its-kind therapies.
- Who are Arrivo BioVentures's investors?
- Arrivo BioVentures's investors include Rex Health Ventures, Orlando Health Ventures, Solas BioVentures.
- How much funding has Arrivo BioVentures raised?
- Arrivo BioVentures has disclosed $43.2M raised across 1 round.
- Where is Arrivo BioVentures headquartered?
- Arrivo BioVentures is headquartered in Morrisville, US.